We offer a unique combination of extensive inhalation device development capability and long experience from pharmaceutical product development.
Dr Orest Lastow, CEO
Mats Johansson
Chairman

 

Serial entrepreneur for over 30 years. Extensive experience from starting and developing companies to multimillion turnover and to make IPO´s. Founder of among others ZetaDisplay AB (NASDAQ First North) and MultiQ Int. AB (NASDAQ Stockholm). Board member and chairman in various companies.

Shares: 915 000

Not independent in relation to the Company’s major shareholders, but independent in relation to the Company and the company management.

Orest Lastow
Board member

PhD, Aerosol Physics

Over 25 years of inhalation experience, mainly from AstraZeneca. Inventor and former project director of AstraZeneca’s new inhalation product. Inventor of 9 different inhalation devices and over 40 patents/patent applications. Author behind many publications and books. Part of developing ISO standards to inhalation devices and nebulizers. Teaches inhaled drug delivery at Lund University, Copenhagen University and Shenyang Pharmaceutical University.
Previously CEO and founder of MVIC AB (Medicon Valley Inhalation Consortium).

Shares: 846 400

Not independent in relation to the Company’s major shareholders, the Company and the company management.

 

Berndt Axelsson
Board member

MSc in Business and Economics

Long experience from management consulting as Consultant Manager/Director at PwC. Worked with projects in both international groups, startups and family owned companies. Earlier experience as CFO at RH Group. Current CEO at Scandinavian Business Seating AB/Vice President for Legal & Risk at SB Seating Group. Entrepreneur and founder of BAN Business Consulting AB and board member and chairman in several companies.

Shares: 314 400

Independent in relation to larger shareholders, and in relation to the Company and the company management.

Sven Totté
Board member

MSc, BEc, MBA, cert. Corp. Gov. 

Experienced International Business Manager with a 25-year track record in complex sales & marketing, leadership & organizational development, product strategy, and entrepreneurship in a variety of industries.

Shares: 24 000

Independent in relation to larger shareholders, and in relation to the Company and the company management.

Mårten Rittfeldt
Board member

MFA

Industrial designer and Creative Director. Co-founder and owner of Zenit Design AB. 20 years of industrial design experience. Experience from a wide range of inhalation device design projects. Many design protections and patents and winner of Red Dot award.

Shares: 512 200

Independent in relation to larger shareholders, and in relation to the Company and the company management.

Maria Öhlander
Board member

MSc Molecular Biology

Over 20 years experience of drug development, clinical research and project management in Pharmaceutical companies and the Biotech industry.
Have worked in a number of therapeutic areas such as metabolic diseases, CNS, oncology, pediatrics and endocrinology.
Currently Chief Scientific Officer at Smartfish AS and board member in a number of companies.

Shares: 2 000

Independent in relation to larger shareholders, and in relation to the Company and the company management.

Leif Bergvall Hansen
Board Member

 

25 years experience from managerial positions in several FMCG companies from blue chip like Nestle to several mid cap companies. Half the time in CEO positions. Have had base in France, UK, US and Denmark.
Currently Group CEO for Scandi Standard a listed leading player in northern Europe within chicken based food products with revenue in excess of 8 BN SEK. Experienced board member.

Shares: 25 974

Independent in relation to larger shareholders, and in relation to the Company and the company management.

Dr Orest Lastow
CEO and Head of R&D

PhD, Aerosol Physics

  • Over 25 years of inhalation experience, mainly from AstraZeneca
  • Inventor and former project director of AstraZeneca’s new inhalation product platform including, device development, formulation development, development of analytical methodology, process development, analytical validation and production of clinical trials supply
  • Inventor of 9 different inhalation devices and has worked on 13 different inhalation devices
  • Over 40 patents/patent applications
  • Frequently invited speaker to inhalation conferences and the author behind many publications and books
  • Co-author of ISO standard on inhalation devices
  • Teaches inhaled drug delivery at Lund University, Copenhagen University and Shenyang Pharmaceutical University
  • Previously CEO and founder of MVIC AB (Medicon Valley Inhalation Consortium)
Dr Mikael Arinder
VP Operations

PhD, Organic Chemistry

  • 8 years of inhalation experience, mainly from AstraZeneca
  • 17 years of project portfolio management, project management, and line management experience within pharmaceutical development and medical device development in AstraZeneca, J&J, and Atos Medical
  • Former project director of AstraZeneca’s new inhalation product platform including: device development, formulation development, development of analytical methodology, process development, analytical validation and production of clinical trials supply
  • 15 years business experience of chemistry and analytical development, mainly from AstraZeneca
  • Author of 12 scientific and 8 conference publications
  • Frequently invited as examination board member at Ph.D. dissertations at Lund University
  • PMI member
Vesna Åkerberg
Director Pharm. Development

MSc. Biomedical Technology

  • 12 years of inhalation experience, mainly from AstraZeneca
  • 8-year experience from line managerial positions in several companies, mainly from product/process/analytical development
  • Worked with product development within the pharmaceutical industry, mainly within formulation development of dry powder formulations
  • Experience from manufacturing of clinical trial material
  • Experience from various powder filling techniques for DPI
Mårten Appelgren
Director Business Development

 

  • DIHM, IHM Business School
  • Over 25 years experience in respiratory drug marketing and sales from several pharmaceutical companies including Boehringer Ingelheim, Schering-Plough, GSK, Novartis and Teva 
  • Experience from a wide range of inhalation devices including launching 8 inhalers in different markets
  • Experience from medical device start-ups
Fredrik Gunnarson
Analytical Development

 

  • 13 years of experience analyzing inhalation products within Analytical chemistry at AstraZeneca
  • Testing everything from concept prototypes to documenting products in GMP for NDA application
  • Developed test equipment and performed testing within AstraZeneca new DPI platform
  • Have worked 5 years within different medical device companies with product development, product testing and design control
Lars Arvidsson
Head of Device Development

 

  • Over 17 years of inhalation experience, mainly from AstraZeneca
  • Device responsible for many AstraZeneca inhalation products
  • Has worked with over 10 different inhalation devices
  • Injection molding, tooling and polymer design expert
  • Co-inventor of AstraZeneca new DPI platform
  • Over 15 patents/patent applications
Richard Johnson
Mechanical Engineer

MSc. Medical Engineering

  • Majors in medical device development and innovation
  • International work experience in industry and research (GER, CN, SWE)
Henrik Svedberg
Mechanical Engineer

 

  • 20 years experience of product development from concept to volume production
  • Experience from developing mobile phones and PTZ surveillance cameras
  • Knowledge in Injection molding and diecasting
Carl Forslund
Head of Industrial Design

MFA Industrial Design

  • Co-founder and owner of Zenit Design
  • Creative Director with 20 years of industrial design experience
  • Experience from a wide range of inhalation device design projects
  • Many design protections and patents
  • Winner of Red Dot award
Mette Gross
CFO

MSc. in Mathematics-Economics

  • Sc. Mathematics-Economics and 20-year experience from finance positions and management in international companies
  • Faxe Paper Pigments, MTG, Ferrosan, Coloplast, and Vigmed Holding
  • Experienced in accounting, financing, controlling, legal, tax, IFRS and IR
  • Experience from listed companies Vigmed Holding AB and Coloplast A/S
Eva Persson
Pharmaceutical Development

 

  • Over 25 years of inhalation experience, mainly from AstraZeneca
  • Deep experience of developing formulations for dry powder inhalers and other dosage forms from pre-clinical phase to production
  • Solid background in GMP and manufacturing material for clinical trials as well as CMC documentations for CTA and registrations
  • Experience in working with Design Control, Design Verification and Risk Management for Medical Device
Mea Lindsjö
Executive Assistant

 

  • 7 years experience providing efficient secretarial and administrativ support to senior management, mainly from Sydkraft Konsult
  • 18 years experience effectively supporting executive level staff, including the CEO and CFO, mainly from Manpower, E.ON Försäljning and Wise Professionals
  • Direct and support experience in sales and marketing
  • Experience from listed companies E.ON Försäljning Sverige AB and BE Group AB
Jakob Samsøe
Analytical Development

MSc. in Analytical Chemistry

  • Over 5 years of working experience as analytical chemist in R&D within the pharma industry
  • Developed and validated UHPLC methods
  • Experience in LC-MS
  • Has worked with polymers and small organic molecules
Kjell Larsson
Scientific Advisory Board

Professor, Respiratory Medicine

  • 30 years of experience in guidelines production for asthma and COPD treatment
  • 15 years as a member of the Heart and Lung Foundation Research Council, including 4 years as its Vice Chairman
  • Author of more than 200 original papers in international peer reviewed journals
  • Author and editor of several books on asthma and COPD
  • Former Editor in chief of European Respiratory Monograph
Lars-Erik Holm
Scientific Advisory Board

MD, PhD in Oncology

  • He has served as Vice Chair and Chair of the Standing Committee of the WHO European Region and been a member of the Executive Board of WHO
  • Former Director General of the National Board of Health and Welfare and Chief Medical Officer (CMO) in Sweden
  • Former Director General of the Swedish Radiation Protection Authority
  • Former Chaiman of UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation)
  • Has represented Sweden in numerous WHO settings
  • Author of more than 300 scientific articles on epidemiology, prevention and health promotion